Azora Therapeutics Financial Statements
NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.85-0.02 (-0.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Azora Therapeutics revenue and earnings
Azora Therapeutics reported a net loss of $8.0 million, compared with a loss of $13.2 million a year earlier. Diluted earnings per share came in at -$11.93.
Summary generated from market data by MetaCap's automated system. Methodology
Azora Therapeutics income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 7.80M | 8.28M | 6.89M | 10.86M | 19.29M | 10.93M | 8.24M | 6.99M | 995.29K |
| Research & Development | 2.62M | 3.23M | 1.27M | 1.95M | 8.40M | 5.85M | 3.97M | 368.46K | 182.11K |
| Operating Income | -7.80M | -8.28M | -6.89M | -10.86M | -19.29M | -10.93M | -8.24M | -6.99M | -995.29K |
| Other Income (Expense) | -177.71K | -4.91M | -113.94K | 63.34K | -228.68K | 34.99K | -346.53K | -4.64M | -144.17K |
| Pretax Income | -7.98M | -13.20M | -7.00M | -10.80M | -19.52M | -10.89M | -8.59M | -11.63M | -1.14M |
| Income Tax | — | — | — | -502 | -94.08K | — | — | — | — |
| Net Income | -7.98M | -13.20M | -5.12M | -12.73M | -19.42M | -10.89M | -8.59M | -11.63M | -1.14M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -11.93 | -68.01 | -3.60 | -12.71 | -1.04 | -0.87 | -0.87 | -2.44 | -0.35 |
| EPS (Diluted) | -11.93 | -68.01 | -3.60 | -12.71 | -1.04 | -0.87 | -0.87 | -2.44 | -0.35 |
| Shares Outstanding (Basic) | 668.63K | 194.06K | — | 25.04M | 18.59M | 12.46M | 9.85M | 4.76M | 3.26M |
| Shares Outstanding (Diluted) | 668.63K | 194.06K | 1.42M | 1.00M | 18.59M | 12.46M | 9.85M | 243.18K | 174.28K |
This table shows 9 annual periods of Azora Therapeutics's income statement, from FY 2025 back to FY 2017, across 11 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a income statement?